PMID- 16951172 OWN - NLM STAT- MEDLINE DCOM- 20071126 LR - 20190406 IS - 1538-7445 (Electronic) IS - 0008-5472 (Linking) VI - 66 IP - 17 DP - 2006 Sep 1 TI - DNA damage binding protein component DDB1 participates in nucleotide excision repair through DDB2 DNA-binding and cullin 4A ubiquitin ligase activity. PG - 8590-7 AB - Functional defect in DNA damage binding (DDB) activity has a direct relationship to decreased nucleotide excision repair (NER) and increased susceptibility to cancer. DDB forms a complex with cullin 4A (Cul4A), which is now known to ubiquitylate DDB2, XPC, and histone H2A. However, the exact role of DDB1 in NER is unclear. In this study, we show that DDB1 knockdown in human cells impaired their ability to efficiently repair UV-induced cyclobutane pyrimidine dimers (CPD) but not 6-4 photoproducts (6-4PP). Extensive nuclear protein fractionation and chromatin association analysis revealed that upon irradiation, DDB1 protein is translocated from a loosely bound to a tightly bound in vivo chromatin fraction and the DDB1 translocation required the participation of functional DDB2 protein. DDB1 knockdown also affected the translocation of Cul4A component to the tightly bound form in UV-damaged chromatin in vivo as well as its recruitment to the locally damaged nuclear foci in situ. However, DDB1 knockdown had no effect on DNA damage binding capacity of DDB2. The data indicated that DDB2 can bind to damaged DNA in vivo as a monomer, whereas Cul4A recruitment to damage sites depends on the fully assembled complex. Our data also showed that DDB1 is required for the UV-induced DDB2 ubiquitylation and degradation. In summary, the results suggest that (a) DDB1 is critical for efficient NER of CPD; (b) DDB1 acts in bridging DDB2 and ubiquitin ligase Cul4A; and (c) DDB1 aids in recruiting the ubiquitin ligase activity to the damaged sites for successful commencement of lesion processing by NER. FAU - Li, Jinyou AU - Li J AD - Department of Radiology, The Ohio State University, Columbus, Ohio 43240, USA. FAU - Wang, Qi-En AU - Wang QE FAU - Zhu, Qianzheng AU - Zhu Q FAU - El-Mahdy, Mohamed A AU - El-Mahdy MA FAU - Wani, Gulzar AU - Wani G FAU - Praetorius-Ibba, Mette AU - Praetorius-Ibba M FAU - Wani, Altaf A AU - Wani AA LA - eng GR - R01 ES012991/ES/NIEHS NIH HHS/United States GR - CA93413/CA/NCI NIH HHS/United States GR - ES2388/ES/NIEHS NIH HHS/United States GR - ES12991/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (CUL4A protein, human) RN - 0 (Cullin Proteins) RN - 0 (DDB1 protein, human) RN - 0 (DDB2 protein, human) RN - 0 (DNA-Binding Proteins) RN - 0 (Gentamicins) RN - 0 (Recombinant Proteins) RN - A08F5XTI6G (antibiotic G 418) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) SB - IM MH - Cullin Proteins/*metabolism MH - *DNA Damage MH - DNA Repair/*genetics MH - DNA-Binding Proteins/genetics/*metabolism MH - Fibroblasts/drug effects/*physiology/radiation effects MH - Gentamicins/pharmacology MH - HeLa Cells MH - Humans MH - Recombinant Proteins/metabolism MH - Transfection MH - Ubiquitin-Protein Ligases/*metabolism MH - Ultraviolet Rays EDAT- 2006/09/05 09:00 MHDA- 2007/12/06 09:00 CRDT- 2006/09/05 09:00 PHST- 2006/09/05 09:00 [pubmed] PHST- 2007/12/06 09:00 [medline] PHST- 2006/09/05 09:00 [entrez] AID - 66/17/8590 [pii] AID - 10.1158/0008-5472.CAN-06-1115 [doi] PST - ppublish SO - Cancer Res. 2006 Sep 1;66(17):8590-7. doi: 10.1158/0008-5472.CAN-06-1115.